Health & bio
Eli Lilly acquires Centessa for roughly $6.3 billion
Dealroom reports Eli Lilly announced March 31 acquisition of Centessa Pharmaceuticals for approximately $6.3 billion, bolstering post-GLP-1 pipeline.
Primary sources · 1
Dealroom reports Eli Lilly announced March 31 acquisition of Centessa Pharmaceuticals for approximately $6.3 billion, bolstering post-GLP-1 pipeline.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.